BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12928487)

  • 1. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction.
    Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R153-7. PubMed ID: 12928487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
    Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
    Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
    Nagasaki K; Miki Y
    Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise.
    Sun Z; Yang P
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2063-8. PubMed ID: 17119029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
    Moon H; Ahn H; Kodell RL; Baek S; Lin CJ; Chen JJ
    Artif Intell Med; 2007 Nov; 41(3):197-207. PubMed ID: 17719213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the science: molecular classifications of breast cancer for clinical diagnostics.
    Robison JE; Perreard L; Bernard PS
    Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
    Miller LD; Liu ET
    Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic approaches to outcome prediction in prostate cancer.
    Febbo PG
    Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome.
    Zhang Z; Chen D; Fenstermacher DA
    BMC Genomics; 2007 Sep; 8():331. PubMed ID: 17883867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparametric pathway-based regression models for analysis of genomic data.
    Wei Z; Li H
    Biostatistics; 2007 Apr; 8(2):265-84. PubMed ID: 16772399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
    Creighton CJ; Rae JM
    Breast Cancer Res; 2006; 8(4):302. PubMed ID: 16834787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico identification of breast cancer genes by combined multiple high throughput analyses.
    Shen D; He J; Chang HR
    Int J Mol Med; 2005 Feb; 15(2):205-12. PubMed ID: 15647832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy number alterations that predict metastatic capability of human breast cancer.
    Zhang Y; Martens JW; Yu JX; Jiang J; Sieuwerts AM; Smid M; Klijn JG; Wang Y; Foekens JA
    Cancer Res; 2009 May; 69(9):3795-801. PubMed ID: 19336569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.